Cassava Sciences Inc SAVA shares are trading higher in Tuesday's after-hours session after new filings showed recent insider buying.
According to a Form 4 filing with the SEC, Cassava director Sanford Robertson purchased 100,000 shares at an average price of $20.69. The shares were purchased in multiple transactions on Aug. 12 at prices ranging from $19.79 to $21.31 per share.
According to a separate Form 4 filing, Cassava CFO Eric Schoen purchased 2,500 shares for $19.95 per share on Aug. 12.
Cassava Sciences is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease.
SAVA Price Action: Cassava has a 52-week high of $62.49 and a 52-week low of $13.84.
The stock was up 31.60% in after-hours at $26.59 at press time, according to Benzinga Pro.
Photo: Konstantin Kolosov from Pixabay.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.